Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15275 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Lucie Mayerova and 13 co-authors. Institution: Department of Cardiology, IKEM, Prague, Czech Republic. Major MEDLINE topics: Coronary Artery Disease, Plaque, Atherosclerotic, Heart Transplantation. Cited 1 times so far (Crossref); 30 references. The full text is freely available in PubMed Central. Funded by: NIBIB NIH HHS, NIH HHS, National Institutes of Health.
Abstract (original language)
Background
There is conflicting evidence on the role of acetylsalicylic acid (ASA) use in the development of cardiac allograft vasculopathy (CAV).
Methods
A nationwide prospective two‐center study investigated changes in the coronary artery vasculature by highly automated 3‐D optical coherence tomography (OCT) analysis at 1 month and 12 months after heart transplant (HTx). The influence of ASA use on coronary artery microvascular changes was analyzed in the overall study cohort and after propensity score matching for selected clinical CAV risk factors.
Results
In total, 175 patients (mean age 52 ± 12 years, 79% male) were recruited. During the 1‐year follow‐up, both intimal and media thickness progressed, with ASA having no effect on its progression. However, detailed OCT analysis revealed that ASA use was associated with a lower increase in lipid plaque (LP) burden ( p = .013), while it did not affect the other observed pathologies. Propensity score matching of 120 patients (60 patient pairs) showed similar results, with ASA use associated with lower progression of LPs ( p = .002), while having no impact on layered fibrotic plaque ( p = .224), calcification ( p = .231), macrophage infiltration ( p = .197), or the absolute coronary artery risk score ( p = .277). According to Kaplan–Meier analysis, ASA use was not associated with a significant difference in survival ( p = .699)
Conclusion
This study showed a benefit of early ASA use after HTx on LP progression. However, ASA use did not have any impact on the progression of other OCT‐observed pathologies or long‐term survival.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, IKEM, Prague, Czech Republic.
- Department of Preventive Cardiology, IKEM, Prague, Czech Republic.
- Iowa Institute for Biomedical Imaging, The University of Iowa, Iowa City, Iowa, USA.
- Cardiovascular and Transplantation Surgery, Brno, Czech Republic.
- Department of Cardiovascular Diseases, St. Anne's University Hospital and Masaryk University Brno, Brno, Czech Republic.
- 2nd Department of Internal Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
ORCID profiles: Lucie Mayerova
Funding
- NIBIB NIH HHS
- NIH HHS
- National Institutes of Health
Cite
APA
Mayerova, L., Wohlfahrt, P., Sonka, M., Chen, Z., Kautzner, J., Melenovsky, V., Karmazin, V., Malek, I., Bedanova, H., Tomasek, A., Ozabalova, E., Krejci, J., Kovarnik, T., & Pazdernik, M. (2024). Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis. Clinical Transplantation. https://doi.org/10.1111/ctr.15275
Vancouver
Mayerova L, Wohlfahrt P, Sonka M, Chen Z, Kautzner J, Melenovsky V, et al. Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis. Clinical Transplantation. 2024. doi:10.1111/ctr.15275
BibTeX
@article{Mayerova2024,
author = {Mayerova, Lucie and Wohlfahrt, Peter and Sonka, Milan and Chen, Zhi and Kautzner, Josef and Melenovsky, Vojtech and Karmazin, Vladimir and Malek, Ivan and Bedanova, Helena and Tomasek, Ales and Ozabalova, Eva and Krejci, Jan and Kovarnik, Tomas and Pazdernik, Michal},
title = {Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15275}
}
EUVIMED